ES2118794T3 - Nueva sintesis de compuestos de 19-nor-vitamina d. - Google Patents

Nueva sintesis de compuestos de 19-nor-vitamina d.

Info

Publication number
ES2118794T3
ES2118794T3 ES92304837T ES92304837T ES2118794T3 ES 2118794 T3 ES2118794 T3 ES 2118794T3 ES 92304837 T ES92304837 T ES 92304837T ES 92304837 T ES92304837 T ES 92304837T ES 2118794 T3 ES2118794 T3 ES 2118794T3
Authority
ES
Spain
Prior art keywords
compounds
vitamin
synthesis
new synthesis
dihydroxivitamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92304837T
Other languages
English (en)
Inventor
Hector Floyd Deluca
Heinrich Konstantine Schnoes
Kato Leonard Perlman
Rolf E Swenson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2118794T3 publication Critical patent/ES2118794T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/532—Cycloaliphatic phosphine oxides or thioxides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBE UNA SINTESIS CONVERGENTE DE COMPUESTOS DE 19-NOR VITAMINA D, ESPECIFICAMENTE 19-NOR-1O,25-DIHIDROXIVITAMINA D3. TAMBIEN SE PUEDE UTILIZAR LA SINTESIS FACILMENTE PARA PREPARAR OTROS COMPUESTOS DE 19-NOR EL PASO CLAVE EN LA SINTESIS ES UNA APLICACION ADECUADA DEL PROCEDIMIENTO DE LYTHGOE, ES DECIR UNA REACCION HORNER-WITTIG DEL ANION DE LITIO DE UN OXIDO DE FOSFINA CON UNA CETONA WINDAUS GRUNDMANN PARA FACILITAR, TRAS CUALQUIER DESPROTECCION NECESARIA, EL COMPUESTO DESEADO DE 19-NOR
ES92304837T 1991-05-28 1992-05-28 Nueva sintesis de compuestos de 19-nor-vitamina d. Expired - Lifetime ES2118794T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70591791A 1991-05-28 1991-05-28

Publications (1)

Publication Number Publication Date
ES2118794T3 true ES2118794T3 (es) 1998-10-01

Family

ID=24835479

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92304837T Expired - Lifetime ES2118794T3 (es) 1991-05-28 1992-05-28 Nueva sintesis de compuestos de 19-nor-vitamina d.

Country Status (11)

Country Link
US (7) US5281731A (es)
EP (1) EP0516410B1 (es)
JP (4) JP2648845B2 (es)
KR (3) KR0160784B1 (es)
AT (1) ATE168996T1 (es)
AU (2) AU650751B2 (es)
CA (2) CA2191993C (es)
DE (1) DE69226402T2 (es)
DK (1) DK0516410T3 (es)
ES (1) ES2118794T3 (es)
IE (1) IE921700A1 (es)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
US5464866A (en) * 1992-08-17 1995-11-07 Alcon Laboratories, Inc. Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
JP2898882B2 (ja) * 1993-04-05 1999-06-02 ウイスコンシン アラムナイ リサーチ フオンデーシヨン ２−位に置換基を有する１９−ノル−ビタミンｄ３ 化合物
AU699200B2 (en) * 1993-07-09 1998-11-26 Roger Bouillon Novel structural analogues of vitamin D
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JPH10509715A (ja) * 1994-11-21 1998-09-22 ウィスコンシン・アルムニ・リサーチ・ファウンデーション １８，１９−ジノル−ビタミンｄ 化合物
US5597815A (en) * 1995-07-13 1997-01-28 Wisconsin Alumni Research Foundation Prevention of hyperphosphatemia in kidney disorder patients
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6316642B1 (en) 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US6306844B1 (en) 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US5843928A (en) * 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6392071B1 (en) 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
AU7653998A (en) * 1997-05-23 1998-12-11 F. Hoffmann-La Roche Ag Cyclohexanediol derivatives
US5936105A (en) * 1997-06-13 1999-08-10 Tetrionics, Inc. 14-EPI-19-nor-vitamin D compounds and methods
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
JP2002509888A (ja) * 1998-03-27 2002-04-02 オレゴン ヘルス サイエンシーズ ユニバーシティー 腫瘍および他の過増殖性疾患の治療におけるビタミンｄおよびその類似体
US6080879A (en) * 1998-05-19 2000-06-27 Tetrionics, Inc. Hexafluoro-vitamin synthesis and crystallization method, solvent and product
US6114317A (en) 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
US5962707A (en) * 1998-08-18 1999-10-05 Wisconsin Alumni Research Foundation 19-nor-vitamin D3 compounds with calcemic activity
US6603030B1 (en) * 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
US6310262B1 (en) 1999-10-18 2001-10-30 Basilea Pharmaceutica Ag Process for preparing retiferol derivatives
DE10019861A1 (de) * 2000-04-18 2001-10-31 Schering Ag Neues Synthesezwischenprodukt, seine mikrobiologische Herstellung und Verwendung zur Synthese von Vitamin D-Derivaten
ES2309069T3 (es) 2000-05-31 2008-12-16 Wisconsin Alumni Research Foundation Compuestos de 2-etil y 2-etiliden-19-nor-vitamina d.
JP4811547B2 (ja) * 2000-10-24 2011-11-09 史衛 佐藤 光学活性シクロヘキセン化合物の製造法及びこの製造に用いる光学活性シクロヘキセン誘導体
US6683219B2 (en) * 2001-07-30 2004-01-27 Wisconsin Alumni Research Foundation Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
US20040258801A1 (en) * 2001-09-27 2004-12-23 Alvin Ling Vitamin fortification of foodstuffs
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
US7023347B2 (en) * 2002-08-02 2006-04-04 Symbol Technologies, Inc. Method and system for forming a die frame and for transferring dies therewith
KR20050120787A (ko) 2003-04-10 2005-12-23 위스콘신 얼럼나이 리서어치 화운데이션 2-프로필리덴-19-노르-비타민 ｄ 화합물
TW200504809A (en) * 2003-06-12 2005-02-01 Matrics Inc Method and system for high volume transfer of dies to substrates
US6894037B2 (en) 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
US7713951B2 (en) 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
US20060012387A1 (en) * 2004-06-29 2006-01-19 Symbol Technologies, Inc. Systems and methods for testing radio frequency identification tags
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US20060225273A1 (en) * 2005-03-29 2006-10-12 Symbol Technologies, Inc. Transferring die(s) from an intermediate surface to a substrate
CN101223135A (zh) * 2005-07-18 2008-07-16 特瓦制药工业有限公司 帕立骨化醇的制备
US20070107186A1 (en) * 2005-11-04 2007-05-17 Symbol Technologies, Inc. Method and system for high volume transfer of dies to substrates
US20070131016A1 (en) * 2005-12-13 2007-06-14 Symbol Technologies, Inc. Transferring die(s) from an intermediate surface to a substrate
US20070139057A1 (en) * 2005-12-15 2007-06-21 Symbol Technologies, Inc. System and method for radio frequency identification tag direct connection test
WO2007105773A1 (ja) 2006-03-15 2007-09-20 Mercian Corporation インデン誘導体の製造方法およびその製造中間体
EP2010483A2 (en) 2006-04-05 2009-01-07 Wisconsin Alumni Research Foundation 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
US20070244657A1 (en) * 2006-04-11 2007-10-18 Drago Randall A Methods and systems for testing radio frequency identification (RFID) tags having multiple antennas
US20110319644A1 (en) 2006-11-02 2011-12-29 Asako Toyoda Process for production of 1-hydroxy-19-norcyclovitamin d derivative and intermediate for the production
ES2544819T3 (es) * 2007-05-30 2015-09-04 Opko IP Holdings II, Inc. Proceso para la producción de precursores de la vitamina D de óxido de fosfina
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
US20090275768A1 (en) 2008-04-30 2009-11-05 Formosa Laboratories, Inc. Preparation of Paricalcitol
US8013176B2 (en) * 2008-09-11 2011-09-06 Alphora Research Inc. Paricalcitol purification
CA2639477C (en) * 2008-09-11 2016-03-22 Alphora Research Inc. Paricalcitol purification
SG173119A1 (en) * 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
CN101671288B (zh) * 2009-10-14 2013-10-30 兰州大学 帕立骨化醇的中间体的制备方法
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN107501317B (zh) * 2017-09-13 2019-08-16 上海皓元医药股份有限公司 一种帕立骨化醇中间体的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607118A (en) * 1981-04-30 1986-08-19 Philip Morris Incorporated Flavor-release β-hydroxy-ester compositions
DE3471928D1 (en) * 1983-01-28 1988-07-14 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4584013A (en) * 1983-05-18 1986-04-22 Ciba-Geigy Corporation Cyclohexanedionecarboxylic acid derivatives with herbicidal and plant growth regulating properties
US4681976A (en) * 1983-12-21 1987-07-21 International Flavors & Fragrances Inc. Process for preparing alkyl substituted and unsubstituted para-carboalkoxy cyclohexanones
US4668817A (en) * 1983-12-21 1987-05-26 International Flavors & Fragrances Inc. Alkyl substituted para-carboalkoxy cyclohexanones
DK157244C (da) * 1984-02-08 1990-04-23 Hoffmann La Roche Calciferolderivater, disse derivater til brug som farmaceutisk aktive stoffer, disse derivater til brug som antiproliferative og differentieringsinducerende aktive stoffer, samt laegemiddel indeholdende disse
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
US4612308A (en) * 1984-11-29 1986-09-16 Hoffmann-La Roche Inc. 25,26-Dehydro-1α,23(S,R)-dihydroxycholecalciferol and its epimers
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
US4755329A (en) * 1985-06-10 1988-07-05 Wisconsin Alumni Research Foundation Process and intermediates for preparing 1α-hydroxyvitamin D compounds
WO1987000834A1 (en) * 1985-08-02 1987-02-12 Leo Pharmaceutical Products Ltd. A/S Novel vitamin d analogues
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US4847012A (en) * 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
US5232836A (en) * 1988-05-04 1993-08-03 Ire-Medgenix S.A. Vitamin D derivatives: therapeutic applications and applications to assays of metabolites of vitamin D
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
NZ232734A (en) * 1989-03-09 1991-11-26 Wisconsin Alumni Res Found 19-nor vitamin d derivatives and pharmaceutical compositions
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds

Also Published As

Publication number Publication date
US5391755A (en) 1995-02-21
DK0516410T3 (da) 1998-10-26
US5563286A (en) 1996-10-08
EP0516410A3 (en) 1993-06-30
US5616759A (en) 1997-04-01
US5486636A (en) 1996-01-23
EP0516410A2 (en) 1992-12-02
ATE168996T1 (de) 1998-08-15
US5281731A (en) 1994-01-25
KR0160936B1 (ko) 1999-01-15
AU5932594A (en) 1994-06-02
AU1712092A (en) 1992-12-03
CA2069374A1 (en) 1992-11-29
AU659774B2 (en) 1995-05-25
IE921700A1 (en) 1992-12-02
CA2069374C (en) 1999-08-31
KR920021505A (ko) 1992-12-18
JP2648845B2 (ja) 1997-09-03
CA2191993A1 (en) 1992-11-29
JP3320025B2 (ja) 2002-09-03
DE69226402D1 (de) 1998-09-03
JPH09118641A (ja) 1997-05-06
US5581006A (en) 1996-12-03
CA2191993C (en) 2002-07-09
KR0160937B1 (ko) 1999-01-15
JP2002201197A (ja) 2002-07-16
US5597932A (en) 1997-01-28
JP2926008B2 (ja) 1999-07-28
JPH11240891A (ja) 1999-09-07
DE69226402T2 (de) 1998-12-10
KR0160784B1 (ko) 1999-01-15
AU650751B2 (en) 1994-06-30
JP3494637B2 (ja) 2004-02-09
JPH05221960A (ja) 1993-08-31
EP0516410B1 (en) 1998-07-29

Similar Documents

Publication Publication Date Title
DK0516410T3 (da) Hidtil ukendt syntese af 19-nor-vitamin D-forbindelser
CA974518A (en) Procedure for the manufacture of 1,3,5 trisubstituted adamantan compounds
ES2113652T3 (es) Pamoato de risperidona.
FR1244468A (fr) Réactions chimiques sous l'action d'une lampe à arc notamment pour la fabrication d'hydrocarbures non saturés
ES2162139T3 (es) Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
IE842494L (en) Pyrimidine derivatives
NO304266B1 (no) Nye estere av bi- og tricykliske aminoalkoholer, i legemidler inneholdende slike, samt deres anvendelse til fremstilling av legemidler
ES2196002T3 (es) Anticuerpos recombinantes para terapia humana.
YU47204B (sh) Derivati didehidro-vitamina d3
ES2054813T3 (es) Formulacion de acetaminofen de liberacion sostenida por via oral y procedimiento para obtenerla.
NO872260L (no) Fremgangsmaate for sliping av silisiumkarbid til pulver.
GB1512658A (en) Metallic inserts for use in an annular well blowout preventer packer unit
ES425853A1 (es) Un nuevo procedimiento para la preparacion de compuestos de4,5-dihidrotetrazolo (1,5-a) quinoleina.
ES479816A1 (es) Procedimiento para la preparacion de hidrato de dioxido de titanio o de una mezcla de hidratos de dioxido de titanio.
ES2118728T3 (es) Procedimiento para la preparacion de 2,3-piridindicarboxilatos sustituidos y no sustituidos a partir de cloromaleato o clorofumarato o sus mezclas.
DE3781653D1 (de) Verwendung von cembrane-diterpene verbindungen zur herstellung von zusammensetzungen, die inhibitoren der freigabe von lysosomen enthalten.
DE69431662D1 (de) Stabilisierte tablettenformulierung
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS57122038A (en) Pure enanthiomer of bicyclo(2,2,2)oct-5- ene-2-one, manufacture and use
ES396287A1 (es) Procedimiento para la obtencion de derivados deal tiazol.
GB1132397A (en) Improvements in or relating to fluorene derivatives and the manufacture thereof
JPS5280747A (en) Buffer memory control system
GB1470393A (en) Drug for the treatment of radiation sickness
GB904999A (en) Improvements in lathe and like tool holders
ATE32063T1 (de) Iminosulfonamide und verfahren zu ihrer herstellung, die pharmazeutische praeparate solche verbindungen enthalten, sowie die verbindungen zur verwendung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 516410

Country of ref document: ES